Compugen Ltd.
Compugen Ltd. (CGEN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CGEN · as of Sep 30, 2025
Ownership Breakdown
71
Institutional Holders
$19.14M
Total Inst. Value
▼ $8.63M vs Q2
94.55M
Shares Outstanding
freeFloat 97.81%
12.45M
13F Shares Held
▼ 2.69M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CGEN largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 3.31M | 3.54% | 3.54% | $4.87B | Nov 12, 2025 | ▲ 277.3K |
RENAISSANCE TECHNOLOGIES LLC biological products, (no diagnostic substances) | 1.41M | 1.50% | 1.50% | $2.07B | Nov 13, 2025 | ▲ 78.2K |
MORGAN STANLEY biological products, (no diagnostic substances) | 1.06M | 1.13% | 1.13% | $1.56B | May 27, 2026 | ▼ 254.4K |
MACQUARIE GROUP LTD biological products, (no diagnostic substances) | 1.02M | 1.09% | 1.09% | $1.50B | Nov 13, 2025 | — held |
TAYLOR FRIGON CAPITAL MANAGEMENT LLC biological products, (no diagnostic substances) | 964.7K | 1.03% | 1.03% | $1.42B | Oct 21, 2025 | ▼ 29.9K |
NORTHERN TRUST CORP biological products, (no diagnostic substances) | 658.9K | 70.45% | 70.45% | $968.59M | Nov 14, 2025 | ▼ 230.8K |
STATE STREET CORP biological products, (no diagnostic substances) | 379.1K | 40.53% | 40.53% | $557.28M | Nov 14, 2025 | ▲ 27.9K |
ATOM INVESTORS LP biological products, (no diagnostic substances) | 330.6K | 35.34% | 35.34% | $485.93M | Nov 14, 2025 | ▲ 1.0K |
YELIN LAPIDOT HOLDINGS MANAGEMENT LTD. biological products, (no diagnostic substances) | 318.9K | 34.09% | 34.09% | $468.71M | Oct 27, 2025 | — held |
UBS GROUP AG biological products, (no diagnostic substances) | 296.6K | 31.71% | 31.71% | $436.00M | Nov 13, 2025 | ▲ 6.2K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
13
Increased
+627.5K shares1
New Positions
first time holders21
Decreased
−2.23M shares0
Sold Out
fully exitedNet shares change (top 50)
1.60M
+627.5K / −2.23M
Net new holders
-7
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CGEN insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
10
Buy transactions
17
Sell transactions
0.59
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Levine Zurit SVP, Business Development | Apr 24, 2026 | Sale | 2,000 | $3.20 | $6.4K | 29.4K | Form 4 ↗ |
Ophir Eran President and CEO | Apr 24, 2026 | Sale | 5,000 | $3.20 | $16.0K | 11.4K | Form 4 ↗ |
Ophir Eran President and CEO | Apr 14, 2026 | Sale | 5,000 | $2.90 | $14.5K | 11.4K | Form 4 ↗ |
Levine Zurit SVP, Business Development | Apr 14, 2026 | Sale | 2,000 | $2.80 | $5.6K | 29.4K | Form 4 ↗ |
Levine Zurit SVP, Business Development | Apr 10, 2026 | Sale | 3,125 | $2.56 | $8.0K | 29.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Compugen Ltd. (CGEN) is primarily owned by institutional investors, who hold approximately 13.2% of total shares outstanding. Company insiders own approximately 2.19%, while retail and public investors account for the remaining 84.64%.
The largest institutional shareholder of Compugen Ltd. is SILVERARC CAPITAL MANAGEMENT, LLC, holding approximately 3.31 million shares — equal to 3.54% of outstanding shares — as of September 30, 2025.
A total of 71 institutional investors currently hold CGEN stock, with a combined institutional value of approximately $19,142,720 as of the most recent 13F filing period.
Frequently asked questions
CGEN ownershipCompugen Ltd. (CGEN) is primarily owned by institutional investors, who hold approximately 13.2% of shares. The largest shareholder is SILVERARC CAPITAL MANAGEMENT, LLC with a 3.54% stake. Company insiders hold 2.19%. Data sourced from SEC Form 13F as of September 30, 2025.